CRP and COVID-19: This study consistently demonstrates that inflammatory indicators CRP and PCT are associated with the prevalence of hyperglycemic crises in T2DM patients with COVID-19, confirming the significant role of inflammation in the pathogenesis of ADC in COVID-19.